{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:57:29Z","timestamp":1776326249499,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM144027, AG076027"],"award-info":[{"award-number":["GM144027, AG076027"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM144027, AG076027, K12TR005467"],"award-info":[{"award-number":["GM144027, AG076027, K12TR005467"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-026-00654-9","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:23:28Z","timestamp":1773055408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel device for in-situ on-demand hydrogen sulfide generation and delivery to increase tissue perfusion to chronic wounds"],"prefix":"10.1186","volume":"20","author":[{"given":"Matthew","family":"Justus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Friedrichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grayson","family":"Silaski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Beckius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierce","family":"Massie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepali","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Self","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mildred","family":"Mattox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Risotto-Urbanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Iturralde-Carillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Marek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristine","family":"Heaps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Shekarriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Kanagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"654_CR1","unstructured":"Walker C. THE SAGE Group releases new estimates for the United States prevalence and incidence of peripheral artery disease (PAD) and critical limb ischemia (CLI). Vasc Dis Manag [Internet]. 2016 Oct 25 [cited 2025 Dec 12]. Available from: https:\/\/www.vasculardiseasemanagement.com\/content\/sage-group-releases-new-estimates-united-states-prevalence-and-incidence-peripheral-artery. [Accessed 15 February 2021]."},{"key":"654_CR2","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","volume":"40","author":"JA Barnes","year":"2020","unstructured":"Barnes JA, Eid MA, Creager MA, Goodney PP. Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease. Arterioscler Thromb Vasc Biol. 2020;40:1808\u201317.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"654_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1524-475X.2009.00543.x","volume":"17","author":"CK Sen","year":"2009","unstructured":"Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, Gottrup F, Gurtner GC, Longaker MT. Human Skin Wounds: A Major and Snowballing Threat to Public Health and the Economy. Wound Repair Regen. 2009;17(6):763\u201371.","journal-title":"Wound Repair Regen"},{"key":"654_CR4","doi-asserted-by":"crossref","unstructured":"Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790\u20131795.","DOI":"10.2337\/diacare.26.6.1790"},{"key":"654_CR5","unstructured":"CDC. Center for disease control, National diabetes fact sheet, 2011. [Online]. Available: http:\/\/www.cdc.gov."},{"key":"654_CR6","unstructured":"Labovitz J. The cost of the diabetic foot. In: 16th Annual NCVH Conference; 2015; New Orleans, USA."},{"issue":"3","key":"654_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/120347540300700305","volume":"7","author":"JT Shen","year":"2003","unstructured":"Shen JT, Falanga V. Innovative therapies in wound healing. J Cutan Med Surg. 2003;7(3):217\u201324.","journal-title":"J Cutan Med Surg"},{"key":"654_CR8","doi-asserted-by":"crossref","unstructured":"Brem H, Sheehan P, Boulton AJ. Protocol for treatment of diabetic foot ulcers. Am J Surg. 2004;187(5A):1S\u201310S.","DOI":"10.1016\/S0002-9610(03)00299-X"},{"issue":"2","key":"654_CR9","first-page":"197","volume":"32","author":"SM Sweitzer","year":"2006","unstructured":"Sweitzer SM, Fann SA, Borg TK, Baynes JW, Yost MJ. What is future Diabet wound care? Diabetes Educ. 2006;32(2):197\u2013210.","journal-title":"What is future Diabet wound care? Diabetes Educ"},{"issue":"24","key":"654_CR10","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","volume":"376","author":"DG Armstrong","year":"2017","unstructured":"Armstrong DG, Boulton A, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367\u201375.","journal-title":"N Engl J Med"},{"issue":"16","key":"654_CR11","first-page":"1","volume":"13","author":"DG Armstrong","year":"2020","unstructured":"Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(16):1\u20134.","journal-title":"J Foot Ankle Res"},{"issue":"11","key":"654_CR12","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1089\/ars.2009.2956","volume":"12","author":"SK Jain","year":"2010","unstructured":"Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, Bocchini JA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal. 2010;12(11):1333\u20137.","journal-title":"Antioxid Redox Signal"},{"key":"654_CR13","doi-asserted-by":"crossref","unstructured":"Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2009;106(51):21972\u201321977.","DOI":"10.1073\/pnas.0908047106"},{"key":"654_CR14","doi-asserted-by":"crossref","unstructured":"Wang R. The role of H\u2082S bioavailability in endothelial dysfunction. Trends Pharmacol Sci. 2015;36(9):568\u2013578.","DOI":"10.1016\/j.tips.2015.05.007"},{"key":"654_CR15","unstructured":"Clark RM. Hydrogen sulfide in wound healing and angiogenesis. In: UNM Department of Surgery Guest Lecturer Series; 2021; Albuquerque (NM), USA."},{"key":"654_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2020.101704","volume":"37","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, Kishore R. Potential role of hydrogen sulfide in diabetes-impaired angiogenesis and ischemic tissue repair. Redox Biol. 2020;37:1\u20139.","journal-title":"Redox Biol"},{"key":"654_CR17","doi-asserted-by":"crossref","unstructured":"Jensen AR, Drucker NA, Khaneki S, Ferkowicz MJ, Yoder MC, DeLeon ER, et al. Hydrogen sulfide: a potential novel therapy for the treatment of ischemia. Shock. 2017;48(5):511\u2013524.","DOI":"10.1097\/SHK.0000000000000894"},{"key":"654_CR18","doi-asserted-by":"crossref","unstructured":"Wang R, Szabo C, Ichinose F, Ahmed A, Whiteman M, Papapetropoulos A. The role of H\u2082S bioavailability in endothelial dysfunction. Trends Pharmacol Sci. 2015;36(9):568\u2013578.","DOI":"10.1016\/j.tips.2015.05.007"},{"key":"654_CR19","doi-asserted-by":"crossref","unstructured":"Costa SK, Muscara MN, Allain T, Dallazen J, Gonzaga L, Buret AG, et al. Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids. Antioxid Redox Signal. 2020;33(14):1003\u20131009.","DOI":"10.1089\/ars.2019.7884"},{"key":"654_CR20","doi-asserted-by":"crossref","unstructured":"Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, et al. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia. 2010;53(8):1722\u20131726.","DOI":"10.1007\/s00125-010-1761-5"},{"key":"654_CR21","doi-asserted-by":"crossref","unstructured":"Zhang L, Yang G, Tang G, Wu L, Wang R. Rat pancreatic level of cystathionine \u03b3-lyase is regulated by glucose level via specificity protein 1 (SP1) phosphorylation. Diabetologia. 2011;54(10):2615\u20132625.","DOI":"10.1007\/s00125-011-2187-4"},{"key":"654_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2020.105119","volume":"161","author":"N Dilek","year":"2020","unstructured":"Dilek N, Papapetropoulos A, Toliver-Kinsky T, Szabo C. Hydrogen sulfide: An endogenous regulator of the immune system. Pharmacol Res. 2020;161:1\u201339.","journal-title":"Pharmacol Res"},{"issue":"17","key":"654_CR23","doi-asserted-by":"publisher","first-page":"11767","DOI":"10.1074\/jbc.M113.524645","volume":"289","author":"P Manna","year":"2014","unstructured":"Manna P, Gungor N, McVie R, Jain SK. Decreased Cystathionine-\u03b3-lyase (CSE) Activity in Livers of Type 1 Diabetic Rats and Peripheral Blood Mononuclear Cells (PBMC) of Type 1 Diabetic Patients. J Biol Chem. 2014;289(17):11767\u201378.","journal-title":"J Biol Chem"},{"key":"654_CR24","doi-asserted-by":"crossref","unstructured":"Casin KM, Calvert JW. Harnessing the benefits of endogenous hydrogen sulfide to reduce cardiovascular disease. Antioxidants (Basel). 2021;10(3):383.","DOI":"10.3390\/antiox10030383"},{"key":"654_CR25","doi-asserted-by":"publisher","first-page":"S483","DOI":"10.12980\/APJTB.4.201414B58","volume":"4","author":"M Dutta","year":"2014","unstructured":"Dutta M, Biswas UK, Chakraborty R, Banerjee P, Raychaudhuri U, Kumar A. Evaluation of plasma H2S levels and H2S synthesis in streptozotocin induced Type-2 diabetes-an experimental study based on Swietenia macrophylla seeds. Asian Pac J Trop Biomed. 2014;4:S483\u2013487.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"10","key":"654_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1089\/ars.2009.2899","volume":"12","author":"M Whiteman","year":"2010","unstructured":"Whiteman M, Li L, Rose P, Tan C-H, Parkinson DB, Moore PK. The Effect of Hydrogen Sulfide Donors on Lipopolysaccharide-Induced Formation of Inflammatory Mediators in Macrophages. Antioxid Redox Signal. 2010;12(10):1147\u201354.","journal-title":"Antioxid Redox Signal"},{"key":"654_CR27","unstructured":"Candela J, Baker M, Koch T. Is hydrogen sulfide the missing link in diabetic wound care? Podiatry Today. 2020;33(8)."},{"issue":"5","key":"654_CR28","first-page":"1","volume":"5","author":"JW Langston","year":"2015","unstructured":"Langston JW, Toombs CF. Defining the minimally effective dose and schedule for parenteral hydrogen sulfide: long-term benefits in a rat model of hindlimb ischemia. Med Gas Res. 2015;5(5):1\u201310.","journal-title":"Med Gas Res"},{"key":"654_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.08.023","volume":"145","author":"W-C Lin","year":"2017","unstructured":"Lin W-C, Huang C-C, Lin S-J, Li M-J, Chang Y, Lin Y-J, Wan W-L, Shih P-C, Sung H-W. In situ depot comprising phase-change materials that can sustainably release a gasotransmitter H2S to treat diabetic wounds. Biomaterials. 2017;145:1\u20138.","journal-title":"Biomaterials"},{"key":"654_CR30","first-page":"1192","volume":"22","author":"G-G Wang","year":"2019","unstructured":"Wang G-G, Li W. Hydrogen sulfide improves vessel formation of the ischemic adductor muscle and wound healing in diabetic db\/db mice. Iran J Basic Med Sci. 2019;22:1192\u20137.","journal-title":"Iran J Basic Med Sci"},{"key":"654_CR31","doi-asserted-by":"crossref","unstructured":"Marutani E, Ichinose F. Emerging pharmacological tools to control hydrogen sulfide signaling in critical illness. Intensive Care Med Exp. 2020;8(1):5.","DOI":"10.1186\/s40635-020-0296-4"},{"key":"654_CR32","doi-asserted-by":"crossref","unstructured":"Wen YD, Wang H, Zhu YZ. The drug developments of hydrogen sulfide on cardiovascular disease. Oxid Med Cell Longev. 2018;2018:1\u201321.","DOI":"10.1155\/2018\/4010395"},{"key":"654_CR33","doi-asserted-by":"crossref","unstructured":"Jin S, Newton A, Cheng H, Zhang Q, Gao W, Zheng Y, et al. Progress of hydrogel dressings with wound monitoring and treatment functions. Gels. 2023;9(9):694.","DOI":"10.3390\/gels9090694"},{"key":"654_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jconrel.2022.10.055","volume":"352","author":"Y Ge","year":"2022","unstructured":"Ge Y, Rong F, Li W, Wang Y. Review Article: On-demand therapeutic delivery of hydrogen sulfide aided by biomolecules. J Controlled Release. 2022;352:586\u201399.","journal-title":"J Controlled Release"},{"key":"654_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.actbio.2019.07.042","volume":"97","author":"A Longchamp","year":"2019","unstructured":"Longchamp A, Kaur K, Macabrey D, Dubuis C, Corpataux JM, Deglise S. Hydrogen sulfide-releasing peptide hydrogel limits the development of intimal hyperplasia in human vein segments. Acta Biomater. 2019;97:374\u201384.","journal-title":"Acta Biomater"},{"issue":"8","key":"654_CR36","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1021\/acsbiomaterials.8b00212","volume":"4","author":"R Raggio","year":"2018","unstructured":"Raggio R, Bonani W, Callone E, Dir\u00e8 S, Gambari L, Grassi F, Motta A. Silk Fibroin Porous Scaffolds Loaded with a Slow-Releasing Hydrogen Sulfide Agent (GYY4137) for Applications of Tissue Engineering. ACS Biomater Sci Eng. 2018;4(8):2956\u201366.","journal-title":"ACS Biomater Sci Eng"},{"key":"654_CR37","unstructured":"Matheson BT, Friedrichsen DM, Brooks BJ, Giacolone J, Clark RM, Shekarriz R. HEALS\u2122: an active hydrogen sulfide delivery technique for accelerated, effective wound healing. Albuquerque (NM): Final report for NIH\/NIGMS Phase I SBIR Grant 1R43GM144027-01;2022."},{"key":"654_CR38","doi-asserted-by":"crossref","unstructured":"Giacolone J, Osofsky R, Matheson B, Perales G, Shekarriz R, Kanagy N, et al. H\u2082S-eluting hydrogels promote in vitro angiogenesis and augment in vivo ischemic wound revascularization. Biomolecules. 2024;14(11):1\u201313.","DOI":"10.3390\/biom14111350"},{"key":"654_CR39","doi-asserted-by":"crossref","unstructured":"Levinn CM, Cerda MM, Pluth MD. Activatable small-molecule hydrogen sulfide donors. Antioxid Redox Signal. 2020;32(2):96\u2013109.","DOI":"10.1089\/ars.2019.7841"},{"key":"654_CR40","doi-asserted-by":"crossref","unstructured":"Rong F, Wang T, Zhou Q, Peng H, Yang J, Fan Q, et al. Intelligent polymeric hydrogen sulfide delivery systems for therapeutic applications. Bioact Mater. 2022;19:198\u2013216.","DOI":"10.1016\/j.bioactmat.2022.03.043"},{"key":"654_CR41","unstructured":"Shekarriz A, Brooks BJ, Friedrichsen DM. Hydrogen sulfide delivery device. US patent application 63\/420,454; 2023 Oct 28."},{"key":"654_CR42","doi-asserted-by":"crossref","unstructured":"Shekarriz R, et al. Sensing and bio-sensing research. Sens Biosens Res. 2020;28:100328.","DOI":"10.1016\/j.sbsr.2020.100328"},{"key":"654_CR43","unstructured":"Shekarriz A, Friedrichsen DM. Transdermal sampling strip and method for analyzing transdermally emitted gases. US patent 10,856,790; 2020 Dec 8."},{"issue":"100523","key":"654_CR44","first-page":"1","volume":"38","author":"BT Matheson","year":"2022","unstructured":"Matheson BT, Osofsky R, Friedrichsen D, Brooks B, Shekarriz R, Clark R, Kanagy N. Validation of the Novel Transdermal Arterial Gasotransmitter Sensor (TAGS\u2122) System in Measuring Transdermal Hydrogen Sulfide in Human Subjects. J Sens BioSensing Res. 2022;38(100523):1\u20133.","journal-title":"J Sens BioSensing Res"},{"issue":"2","key":"654_CR45","first-page":"1","volume":"9","author":"BT Matheson","year":"2023","unstructured":"Matheson BT, Osofsky RB, Friedrichsen DM, Brooks BJ, Giacolone J, Khotan M, Shekarriz R, Pankratz VS, Lew EJ, Clark RM, Kanagy NL. A novel, microvascular evaluation method and device for early diagnosis of peripheral artery disease and chronic limb-threatening ischemia in individuals with diabetes. J Vasc Surg Cases Innov Tech. 2023;9(2):1\u201310.","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"654_CR46","doi-asserted-by":"crossref","unstructured":"Patil P, et al. Porcine ischemic wound-healing model for preclinical testing of degradable biomaterials. Tissue Eng Part C Methods. 2017;23(11):754\u2013762.","DOI":"10.1089\/ten.tec.2017.0202"},{"issue":"3","key":"654_CR47","first-page":"211","volume":"37","author":"S Roy","year":"2009","unstructured":"Roy S, Biswas S, Khanna S, Gordillo G, Bergdall V, Green J, Marsh CB, Gould LJ, Sen CK. Charact preclinical model chronic ischemic wound Physiol Genomics. 2009;37(3):211\u201324.","journal-title":"Charact preclinical model chronic ischemic wound Physiol Genomics"},{"key":"654_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1152\/physrev.00028.2021","volume":"103","author":"G Cirino","year":"2023","unstructured":"Cirino G, Szabo C, Papapetropoulos A. Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs. Physiol Rev. 2023;103:31\u2013276.","journal-title":"Physiol Rev"},{"key":"654_CR49","first-page":"3646","volume":"21","author":"Z Altaany","year":"2014","unstructured":"Altaany Z, Moccia F, Munaron L, Mancardi D, Wang R. Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide. CurrMedChem. 2014;21:3646\u201361.","journal-title":"CurrMedChem"},{"key":"654_CR50","doi-asserted-by":"crossref","unstructured":"Ding J, Xu K, Xu H, Ji J, Qian Y, Shen J. Advances in gas therapeutics for wound healing: mechanisms, delivery materials, and prospects. Small Struct. 2024;5:2300151.","DOI":"10.1002\/sstr.202300151"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-026-00654-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00654-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00654-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:22:38Z","timestamp":1776324158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13036-026-00654-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1186\/s13036-026-00654-9","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were performed under the OLAW Assurances OLAW Assurance D16-00511 \/ USDA Registration 74-R-0012 (TAMU) and D16-00228\/USDA Registration # 85-R-0014 (UNM).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Reza Shekarriz is the director of Exhalix LLC, a for-profit R&D organization and commercialization of the device hereto presented in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}